skip navigation links
National Cancer Institute
Enterprise Vocabulary Services
Box
NCIm Version: 201808 (Browser Version 2.9, using LexEVS 6.5.1)
SearchBox Top
SearchBox Bottom
Pseudohypoaldosteronism (CUI C0033805) Suggest changes to this concept
Add to Cart

Terms & Properties

Concept Unique Identifier (CUI): C0033805

NCI Thesaurus Code: C85034  (see NCI Thesaurus info)

Semantic Type: Disease or Syndrome

NCIt Definition: An inherited or acquired disorder of electrolyte metabolism, characterized by the inability of the renal tubules to respond to aldosterone. It is manifested by hyperkalemic metabolic acidosis, urinary salt wasting, normal or increased aldosterone secretion and normal glomerular filtration rate.

HPO Definition: A state of renal tubular unresponsiveness or resistance to the action of aldosterone. [HPO:probinson]

MSH Definition: A heterogeneous group of disorders characterized by renal electrolyte transport dysfunctions. Congenital forms are rare autosomal disorders characterized by neonatal hypertension, HYPERKALEMIA, increased RENIN activity and ALDOSTERONE concentration. The Type I features HYPERKALEMIA with sodium wasting; Type II, HYPERKALEMIA without sodium wasting. Pseudohypoaldosteronism can be the result of a defective renal electrolyte transport protein or acquired after KIDNEY TRANSPLANTATION.

Synonyms & Abbreviations: (see Synonym Details)
Pseudohypoadrenocorticalism
Pseudohypoaldosteronism (disorder)
Pseudohypoaldosteronism [Disease/Finding]
Pseudohypoaldosteronisms
Pseudohypoaldosteronism

External Source Codes: 
NCI Thesaurus Code C85034 (see NCI Thesaurus info)

Other Properties: Property Definitions
Name Value Source
ACTIVE 1 SNOMEDCT_US
AQL BL CF CI CL CN CO DG DH DI DT EC EH EM EN EP ET GE HI IM ME MI MO NU PA PC PP PS PX RH RT SU TH UR VE VI MSH
CASE_SIGNIFICANCE_ID 900000000000448009 SNOMEDCT_US
Contributing_Source NICHD NCI
CTV3ID XUKfH SNOMEDCT_US
DC 1 MSH
DEFINITION_STATUS_ID 900000000000074008 SNOMEDCT_US
DX 19910101 MSH
EFFECTIVE_TIME 20020131 SNOMEDCT_US
FX D018161 MSH
FX D053503 MSH
HN 1991(1988); use RENAL TUBULAR TRANSPORT, INBORN ERRORS 1988-90 MSH
HPO_COMMENT Pseudohypoaldosteronism is characterized by hyperkalemia, metabolic acidosis, and normal glomerular filtration rate. This term refers to the phenotypic finding of pseudohypoaldosteronism rather than the disease of idiopathic pseudohypoaldosteronism. HPO
MDA 19870313 MSH
MESH_DEFINITION A heterogeneous group of disorders characterized by renal electrolyte transport dysfunctions. Congenital forms are rare autosomal disorders characterized by neonatal hypertension, HYPERKALEMIA, increased RENIN activity and ALDOSTERONE concentration. The Type I features HYPERKALEMIA with sodium wasting; Type II, HYPERKALEMIA without sodium wasting. Pseudohypoaldosteronism can be the result of a defective renal electrolyte transport protein or acquired after KIDNEY TRANSPLANTATION. NDFRT
MESH_DUI D011546 NDFRT
MESH_NAME Pseudohypoaldosteronism NDFRT
MESH_UI M0017948 NDFRT
MMR 20160623 MSH
MN C12.777.419.815.770 MSH
MN C13.351.968.419.815.770 MSH
MN C16.320.565.861.770 MSH
MN C18.452.648.861.770 MSH
NDFRT_KIND DISEASE_KIND NDFRT
NICHD_Hierarchy_Term Pseudohypoaldosteronism NCI
NUI N0000002517 NDFRT
PM 1991; see RENAL TUBULAR TRANSPORT, INBORN ERRORS 1988-90 MSH
PRIMARY_PATH 10080593$10001349$10014699$10010331$Pseudohypoaldosteronism$Adrenal disorders congenital$Endocrine disorders congenital$Congenital, familial and genetic disorders MDR
RXAUI 3225747 RXNORM
RXAUI 3225748 RXNORM
RXCUI 1022805 RXNORM
SID HP:0008228 HPO
SMQ_TERM_ADDVERSION 21.0 MDR
SMQ_TERM_CAT A MDR
SMQ_TERM_LEVEL 4 MDR
SMQ_TERM_LMVERSION 21.0 MDR
SMQ_TERM_SCOPE 2 MDR
SMQ_TERM_STATUS A MDR
SMQ_TERM_WEIGHT 0 MDR
SNOMED_CID 77098009 NDFRT
SUBSET_MEMBER 447562003~CORRELATIONID~447561005 SNOMEDCT_US
SUBSET_MEMBER 447562003~MAPADVICE~ALWAYS E27.4 SNOMEDCT_US
SUBSET_MEMBER 447562003~MAPCATEGORYID~447637006 SNOMEDCT_US
SUBSET_MEMBER 447562003~MAPGROUP~1 SNOMEDCT_US
SUBSET_MEMBER 447562003~MAPPRIORITY~1 SNOMEDCT_US
SUBSET_MEMBER 447562003~MAPRULE~TRUE SNOMEDCT_US
SUBSET_MEMBER 447562003~MAPTARGET~E27.4 SNOMEDCT_US
SUBSET_MEMBER 6011000124106~CORRELATIONID~447561005 SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPADVICE~ALWAYS E88.89 | CONSIDER ADDITIONAL CODE TO IDENTIFY SPECIFIC CONDITION OR DISEASE SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPCATEGORYID~447637006 SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPGROUP~1 SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPPRIORITY~1 SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPRULE~TRUE SNOMEDCT_US
SUBSET_MEMBER 6011000124106~MAPTARGET~E88.89 SNOMEDCT_US
SUBSET_MEMBER 900000000000497000~MAPTARGET~XUKfH SNOMEDCT_US
SUBSET_MEMBER 900000000000508004~ACCEPTABILITYID~900000000000548007 SNOMEDCT_US
SUBSET_MEMBER 900000000000508004~ACCEPTABILITYID~900000000000549004 SNOMEDCT_US
SUBSET_MEMBER 900000000000509007~ACCEPTABILITYID~900000000000548007 SNOMEDCT_US
SUBSET_MEMBER 900000000000509007~ACCEPTABILITYID~900000000000549004 SNOMEDCT_US
TERMUI T034093 MSH
TH NLM (1988) MSH
TYPE_ID 900000000000003001 SNOMEDCT_US
TYPE_ID 900000000000013009 SNOMEDCT_US

Additional Concept Data:  (none)

URL to Bookmark: https://ncim-stage.nci.nih.gov/ncimbrowser/ConceptReport.jsp?dictionary=NCI Metathesaurus&code=C0033805

Mainbox Bottom